Time-series analysis of recent antihyperglycemic medication prescribing trends for a diverse sample of Medicare enrollees with type 2 diabetes mellitus in an integrated health system

Miller, Michael J DrPH, RPh, FAPhA
DiNucci, Anna J MPH
Jalalzai, Rabia MD, MPH
Rabinovich, Nonna MS
Roblin, Douglas W PhD

Mid-Atlantic Permanente Research Institute (MAPRI), Mid-Atlantic Permanente Medical Group, Rockville, MD, USA
Mid-Atlantic Permanente Research Institute (MAPRI), Mid-Atlantic Permanente Medical Group, Rockville, MD, USA
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Mid-Atlantic Permanente Research Institute (MAPRI), Mid-Atlantic Permanente Medical Group, Rockville, MD, USA
Mid-Atlantic Permanente Research Institute (MAPRI), Mid-Atlantic Permanente Medical Group, Rockville, MD, USA

Address correspondence to Dr. Miller ([email protected]).

Revised March 21, 2022

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

American Journal of Health-System Pharmacy 79(12):p 950-959, June 15, 2022. | DOI: 10.1093/ajhp/zxac056